Company / Financials
LIFECORE BIOMEDICAL, INC. \DE\ Financials
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$524.2M
FY2019 · +9.9% YoY
Net Income
$10.6M
FY2019 · +191.0% YoY
Profit Margin
2.0%
FY2019 · net income / revenue
ROE
4.2%
FY2019 · return on equity
Total Assets
$404.7M
FY2019
Total Debt
$97.0M
0.38x debt/equity
Equity
$252.6M
FY2019
ROA
2.6%
FY2019 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$524.2M+9.9% YoYNet Income HistoryProfit after all expenses and taxes$10.6M+191.0% YoYGross Profit HistoryRevenue minus cost of goods sold$79.2M+18.6% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$390.6M-4.8% YoYOperating Income HistoryProfit from core business operations before interest and taxes$14.7M+171.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$52.5M+13.7% YoYR&D Expense HistoryResearch and development spending$9.5M+31.1% YoYInterest Expense HistoryCost of borrowing and debt obligations$1.6MIncome Tax HistoryTotal income tax expense$4.0M+152.4% YoYEPS (Basic) HistoryBasic earnings per share$0.39+190.7% YoY